This morning in London, Merck and the Wellcome Trust unveiled an unusual
joint vaccine development effort, a $ 145 million non-profit research institute to be formed in India by the end of next year.
The project is a
joint effort of leading European groups working in the field of
vaccine development, and is coordinated by the European Vaccine Initiative
vaccine development, and is coordinated by the European
Vaccine Initiative
Vaccine Initiative (EVI).